A Protein Complex from Human Milk Enhances the Activity of Antibiotics and Drugs against Mycobacterium tuberculosis
Author(s) -
Virginia Meikle,
AnnKristin Mossberg,
Avishek Mitra,
Anders Håkansson,
Michael Niederweis
Publication year - 2018
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01846-18
Subject(s) - tuberculosis , mycobacterium tuberculosis , antibiotics , infectious agent , medicine , drug , microbiology and biotechnology , human immunodeficiency virus (hiv) , virology , infectious disease (medical specialty) , biology , immunology , disease , pharmacology , pathology
Mycobacterium tuberculosis , the causative agent of human tuberculosis (TB), has surpassed HIV/AIDS as the leading cause of death from a single infectious agent. The increasing occurrence of drug-resistant strains has become a major challenge for health care systems and, in some cases, has rendered TB untreatable.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom